Literature DB >> 25643038

[Incidence and Costs of 1:1 Care in Psychiatric Hospitals in Germany - A Descriptive Analysis Based on the VIPP Project Data Set].

André Nienaber1, Michael Schulz2, Rüdiger Noelle2, Hauke Felix Wiegand3, Claus Wolff-Menzler4, Sibylle Häfner4, Florian Seemüller5, Frank Godemann3, Michael Löhr2.   

Abstract

OBJECTIVE: 1:1 care is applied for patients requiring close psychiatric monitoring and care like patients with acute suicidality. The article describes the frequency of 1:1 care across different diagnoses and age groups in German psychiatric hospitals.
METHODS: The analysis was based on the VIPP Project from the years 2011 and 2012. A total of 47 hospitals with more than 120,000 cases were included. Object of the analysis was the OPS code 9-640.0 1:1 care. The evaluation was performed on case level.
RESULTS: Data of 47 hospitals were included. Of the 121,454 cases evaluated in 2011 3.8 % documented a 1:1 care within the meaning of OPS 9-640.0 additional code. Of the 66 245 male cases a 1:1 care was documented in 3.5 % and the 55 207 female cases was 4.1 %. Compared to 2011, the proportion of 1:1 care in 2012 rose to 4.8 %.
CONCLUSION: The results show that 1:1 care is frequently applied in German psychiatric hospitals. The Data of the VIPP project have proven to be a useful tool to gain information on the frequency of cost-intensive interventions in German psychiatric hospitals. Further analyses should create the possibility of evaluation at the level of the individual codes. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2015        PMID: 25643038     DOI: 10.1055/s-0034-1387526

Source DB:  PubMed          Journal:  Psychiatr Prax        ISSN: 0303-4259


  1 in total

1.  [Outsourcing of nursing staff costs in psychiatry? : A secondary data analysis of possible effects on the remuneration system in psychiatry].

Authors:  Julian Schwarz; Martin Heinze; Martin Holzke; Andreas Klär; Michael Löhr; Reinhard Schaffert; Jan Wolff
Journal:  Nervenarzt       Date:  2021-03-19       Impact factor: 1.214

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.